Our most advanced 4-in-1 genetic test offers increased accuracy and confidence for embryo transfer.
Our custom and validated technology that combines next-generation sequencing (NGS) with advanced algorithms and machine learning, enabling the analysis of genomic data from embryos with exceptional accuracy and reliability.
PGT-A Plus enables the detection of both haploidy and triploidy. This crucial assessment ensures the selection of embryos with the correct chromosomal content, minimizing the risk of genetic abnormalities. PGT-A Plus also increases the number of viable euploid embryos available for transfer by detecting true 2PN (diploid) embryos from among morphologically identified 0, 1 and 2.1/3PN embryos.
Our quality control process includes Cohort check analysis, where we employ DNA fingerprinting techniques. This ensures accurate identification, differentiation and the assurance that the tested embryo is genetically related to the others in the patient’s cohort reducing the risk of sample mix-ups due to human error.
We have implemented measures to identify and detect both external cell/DNA and maternal cell contamination increasing the accuracy and confidence of the testing process significantly reducing the risk of misdiagnosis.
PGT-A Plus uses two independent analysis on every sample to deliver a comprehensive 4-in-1 genetic test for aneuploidy in embryos.
Offers enhanced confidence with robust and accurate results, utilizing two independent analyses to detect abnormalities.
Increases the number of viable embryos available for transfer.
Strengthened by the power of big data and artificial intelligence, effectively overcoming the limitations of human subjectivity and greatly reducing the risk of human error.
Enhances accuracy and reduces the risk of misdiagnosis by detecting external and maternal cell DNA contamination.
Maximizes the likelihood of successful pregnancy by carefully identifying optimal embryos for transfer.
Provides confirmation of genetic relatedness between all samples in a cohort without the need for additional parental samples.
Reduces the risk of miscarriage due to previously undetected abnormalities (e.g. triploidy).
Ensures enhanced quality control in the laboratory procedures conducted within your IVF lab, providing greater assurance.
While any couple can have an embryo with aneuploidy, the chances can increase with the following factors:
